ArticleScientific reports2025
Compensator-based small animal IMRT enables conformal preclinical dose painting: application to tumor hypoxia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Retrospective analysis and IMRT replanning of a 3D-CRT murine dose painting study for preclinical oxygen-guided radiotherapy.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Techniques for preclinical intensity modulated radiation therapy are being developed to improve translation by replicating the clinical paradigm. This study presents the first treatment planning comparison between small animal IMRT (SA-IMRT) and three-dimensional conformal radiotherapy (CRT) in a model application, oxygen-guided dose painting of tumor hypoxia, using actual mouse data. A novel compensator-based platform was employed to generate SA-IMRT and CRT plans with 2-15 beam angles for seventeen mice with fibrosarcoma tumors. The whole tumor received a dose of 22.5 Gy, with a simultaneous integrated boost of 13 Gy to hypoxic voxels identified via electron paramagnetic resonance imaging. Plan quality was assessed using the Paddick conformity index (CI), uniformity, and dose volume histograms. For 3-angles, SA-IMRT yielded significantly improved dose conformity (median hypoxic CI = 0.45 vs. 0.17), tumor dose uniformity (11.0% vs. 14.3%), and dosimetric spread between boost and non-boost targets (D50% difference = 13.0 Gy [ideal], 13.1 Gy [SA-IMRT], 7. 3 Gy [CRT]). No significant improvement in CI was associated with > 3 beam angles (Wilcoxon signed-rank test, p < 0.05). This study demonstrates that SA-IMRT provides significant improvements in radiation plan quality and yields dose distributions that more closely mimic the clinical setting relative to current CRT approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.